Clinical Trial Update: Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sofosbuvir and ribavirin in adults with chronic hepatitis C and cirrhosis, including patients with portal hypertension and with or with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Decompensated Cirrhosis
• Hepatitis C
• Portal Hypertension

Drugs mentioned

• Ribavirin (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2016-02-24